Form 4: Quest Diagnostics Director Acquires Shares
Statement of Changes in Beneficial Ownership
Quest Diagnostics Director Timothy C. Wentworth acquired 1,142 shares of common stock through an award of restricted stock units.
Summary
- Timothy C. Wentworth, a Director at Quest Diagnostics Inc., acquired 1,142 shares of common stock on May 20, 2026.
- The acquisition was made through an award of restricted stock units.
- Following this transaction, Wentworth beneficially owns 1,358 shares of common stock.
- The acquisition was made at a price of $0, indicating it was an award rather than a purchase.
- The filing also notes that the amount includes shares acquired via dividend reinvestment since the reporting person's last filing, pursuant to the Amended and Restated Deferred Compensation Plan for Directors.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing. While insider buying can be positive, this specific transaction is an award of restricted stock units and dividend reinvestment, which is a standard part of director compensation and not necessarily indicative of a strong conviction to purchase shares on the open market.
Positives
- Director acquisition of company stock can signal confidence in the company's future prospects.
- The acquisition of 1,142 shares by a Director is a direct investment in the company.
Future Outlook
No specific future outlook or guidance is provided in this filing, as it pertains to a change in beneficial ownership.
Industry Context
StockSavvy.ai notes that insider transactions, such as this acquisition of shares by a director, are closely watched by the market as potential indicators of management's confidence in the company's performance and future prospects within the diagnostics industry.
Stakeholder Impact
- Shareholders: May view the director's acquisition of shares positively, interpreting it as a sign of confidence in the company's value and future performance.
- Employees: The transaction is unlikely to have a direct impact on employees.
Key Dates
| Date | Description |
|---|---|
| 05/20/2026 | Transaction Date for acquisition of common stock. |
| 05/21/2026 | Signature Date of the filing. |
Keywords
Quest Diagnostics, DGX, Form 4, Insider Trading, Director, Stock Acquisition, Restricted Stock Units, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.